The US researchers at the Baylor College of Medicine, Texas Children’s Hospital have said the follow-up observations mark the ...

Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of ...

She’s had two healthy pregnancies since undergoing the trial, which uses modified white blood cells to attack cancer cells. Doctors believe she's the longest-surviving cancer patient to have received ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Research analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Wednesday. The brokerage set a “hold” rating on the ...

Some New York doctors are working on new ways to treat advanced cancers. Chimeric Antigen Receptor, or CAR, T-cell therapy treats certain blood cancers by genetically modifying a person’s T-cells to ...

As global markets navigate a landscape marked by rising inflation and cautious monetary policies, U.S. stock indexes edge toward record highs with growth stocks outpacing their value counterparts. In ...

The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.

Think of it this way — the human body is a kingdom which is healthy, prosperous and functions peacefully. Every once in a while, invaders from the pat ...